Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GABAeron iPSC-derived GABAergic interneuron progenitor cells
- Development stage
- Preclinical
- Lead developer
- GABAeron
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
- Administration
- Intracerebral
01
Overview
GABAeron is developing a first-in-class cell replacement therapy utilizing human induced pluripotent stem cell (iPSC)-derived GABAergic interneuron progenitor cells. The therapy specifically targets the restoration of somatostatin-positive (SST) interneurons within the dentate gyrus of the hippocampus. This approach is designed to address GABAergic interneuron dysfunction, particularly in individuals carrying the apoE4 allele, which is a major genetic risk factor for Alzheimer's disease. By transplanting these progenitor cells, the therapy aims to integrate into existing neural circuits, restore inhibitory signaling, and improve cognitive functions. Beyond Alzheimer's disease, the company is exploring applications in Down's syndrome and epilepsy, where similar inhibitory deficits occur. Preclinical studies in mouse models have demonstrated that the transplanted cells mature, integrate, and restore normal hippocampal activity and memory function.
- Other names
- GABAergic interneuron progenitor cellsSST-positive interneuron cell therapyiPSC-derived GABAergic interneuron progenitor cells
Beyond the preview
Go deeper on GABAeron iPSC-derived GABAergic interneuron progenitor cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GABAeron iPSC-derived GABAergic interneuron progenitor cells.